MGC Pharma delivers update on R&D and commercial strategy
MGC Pharmaceuticals (ASX: MXC, OTC: MGCLF) has released an...
Research
BOD completes Phase I on medicinal cannabis wafer
The trial shows the product is safe for human use.
Impression Healthcare goes deep on clinical research.
The partnership is for medicinal cannabis research and commercialisation.
Australia medicinal cannabis report shows falling prices.
The report details key insights on patient numbers, consumption, and pricing.
Medicinal Cannabis Research in Australia – A Summary
Australia is a world leader in medicinal cannabis clinical research.
MedLab releases update on Nanabis
Nanabis contains a 1:1 ratio of CBD and THC for the treatment of chronic pain.
Asterion collaborates with UQ on research of clonal propagation of cannabis plants.
An 18-month, 'proof-of-concept' program for the clonal propagation of cannabis plants.
Medicinal cannabis patents granted
Zelda and US company JC Pharma Inc have been granted patents for their novel medicinal cannabis technologies.
Botanix receives endorsement by American Academy of Dermatology
Botanix is currently running medicinal cannabis Phase 2 clinical trials on acne and atopic dermatitis, and Phase 1B on psoriasis.
Research uncovers targeted pathway for treatment of breast cancer.
Growing evidence of THC as a treatment option for HER2+ breast cancer.